Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: Correlation with protection from CMV disease

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 4, 2006, Pages 585-588

  Stone, S F ^a   Price, P ^b,c   French, M A ^b,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Immediate early 1; Interferon ; Perforin; pp65

Indexed keywords

ANTIRETROVIRUS AGENT; CD8 ANTIGEN; CYTOMEGALOVIRUS ANTIGEN PP65; GAMMA INTERFERON; IMMEDIATE EARLY PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN;

ARTICLE; CD8+ T LYMPHOCYTE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INHIBITION KINETICS; LYMPHOCYTE COUNT; MEMORY T LYMPHOCYTE; VIRUS IMMUNITY; VIRUS REACTIVATION; VIRUS REPLICATION;

CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HIV INFECTIONS; HUMANS; INTERFERON TYPE II; MEMBRANE GLYCOPROTEINS; PHOSPHOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; VIRAL MATRIX PROTEINS;

EID: 33645121725     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl049     Document Type: Article

References (35)

1. Kondo K, Mocarski ES. Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand J Infect Dis 1995; 99: 63-7.
2. Hahn G, Jores R, Mocarski ES. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci USA 1998; 95: 3937-42.
3. Gratama JW, van Esser JW, Lamers CH et al. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001; 98: 1358-64.
4. Khan N, Bruton R, Taylor GS et al. Identification of cytomegalovirusspecific cytotoxic T lymphocytes in vitro is greatly enhanced by the use of recombinant virus lacking the US2 to US11 region or modified vaccinia virus Ankara expressing individual viral genes. J Virol 2005; 79: 2869-79.
5. Salkowitz JR, Sieg SF, Harding CV et al. In vitro human memory CD8T cell expansion in response to cytomegalovirus requiresCD4+ T cell help. J Infect Dis 2004; 189: 971-83.
6. Lacey SF, Martinez J, Gallez-Hawkins G et al. Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem-cell transplant recipients. J Infect Dis 2005; 191: 977-84.
7. Elkington R, Walker S, Crough T et al. Ex vivo profiling of CD8+ T cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol 2003; 77: 5226-40.
8. La Rosa C, Wang Z, Lacey SF et al. Characterization of hostimmunity to cytomegalovirus pp150 (UL32). Hum Immunol 2005, 66: 116-26.
9. Wills MR, Carmichael AJ, Mynard K et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T cell receptor usage of pp65-specific CTL. J Virol 1996; 70: 7569-79.
10. Khan N, Cobbold M, Keenan R et al. Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype. J Infect Dis 2002; 185: 1025-34.
11. Toro AI, Ossa J. PCR activity of CMV in healthy CMV-seropositive individuals: Does latency need redefinition? Res Virol 1996; 147: 233-8.
12. Dunn HS, Haney DJ, Ghanekar SA et al. Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. J Infect Dis 2002; 186: 15-22.
13. Almanzar G, Schwaiger S, Jenewein B et al. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T cell repertoire, which may be the basis for an imbalance in the cytokine production in elderly persons. J Virol 2005; 79: 3675-83.
14. Deayton JR, Sabin CA, Johnson MA et al. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet 2004; 363: 2116-21.
15. Springer KL, Weinberg A. Cytomegalovirus infection in the era of HAART: Fewer reactivations and more immunity. J Antimicrob Chemother 2004; 54: 582-6.
16. Bronke C, Palmer NM, Jansen CA et al. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease. J Infect Dis 2005; 191: 873-80.
17. Stone SF, Price P, Khan N et al. HIV patients on antiretroviral therapy have high frequencies of CD8+ T cells specific for immediate early protein-1 of cytomegalovirus. AIDS 2005; 19: 555-62.
18. Kaiser L, Perrin L, Chapuis B et al. Improved monitoring of cytomegalovirus infection after allogeneic hematopoieticstemcell transplantation by an ultrasensitive plasma DNA PCR assay. J Clin Microbiol 2002;40: 4251-5.
19. Giovannetti A, Pierdominici M, Marziali M et al. Persistently biased T cell receptor repertoires in HIV-1-infected combination antiretroviral therapy-treated patients despite sustained suppression of viral replication. J Acquir Immune Defic Syndr 2003; 34: 140-54.
20. Jabs DA, Gilpin AMK, Min YI et al. HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial. AIDS 2002; 16: 877-87.
21. Forthal DN, Landucci G, Haubrich R et al. Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients. J Infect Dis 1999; 180: 1338-41.
22. Boppana SB, Polis MA, Kramer AA et al. Virus specific antibody responses to human cytomegalovirus (HCMV) in human immunodeficiency virus type 1-infected persons with HCMV retinitis. J Infect Dis 1995; 171: 182-5.
23. Rasmussen L, Morris S, Wolitz R et al. Deficiency in antibody response to human cytomegalovirus glycoprotein gH in human immunodeficiency virus-infected patients at risk for cytomegalovirus retinitis. J Infect Dis 1994; 170: 673-77.
24. Studies of Ocular Complications of AIDS Research Group. MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Arch Ophthalmol 1997; 115: 1528-36.
25. Weinberg A, Tierney C, Kendall MA et al. Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy. J Infect Dis 2006; 193: 488-93.
26. Sacre K, Carcelain G, Cassoux N et al. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease. J Exp Med 2005; 201: 1999-2010.
27. Bunde T, Kirchner A, HoffmeisterB et al. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 2005; 201: 1031-6.
28. Van Leeuwen EM, Gamadia LE, Baars PA et al. Proliferation requirements of cytomegalovirus-specific, effector-type human CD8+ T cells. J Immunol 2002; 169: 5838-43.
29. Bekker V, Bronke C, Scherpbier HJ et al. Cytomegalovirus rather than HIV triggers the out growth of effector CD8+CD45RA+CD27-T cells in HIV-1-infected children. AIDS 2005; 19: 1025-34.
30. Jacobson MA, Maecker HT, Orr PL et al. Results of a cytomegalovirus (CMV)-specific CD8+/inteferton-γ+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in patients with AIDS with CMV retinitis. J Infect Dis 2004; 189: 1362-73.
31. Yeni PG, Hammer SM, Hirsch MS et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA 2004; 292: 251-65
32. Khan N, Shariff N, Cobbold M et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002; 169: 1984-92.
33. Crum NF, Blade KA. Cytomegalovirus retinitis after immune reconstitution. AIDS Read 2005; 15: 186-8.
34. Peggs KS, Verfuerth S, Pizzey A et al. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus specific T cell lines. Lancet 2003; 362: 1375-7.
35. Cobbold M, Khan N, Pourgheysari B et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med 2005; 202: 379-86.